FDA expands access to artificial heart valve to inoperable patients

Author(s):

On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available to patients who have inoperable aortic valve stenosis. Read More.

LEAVE A REPLY

Please enter your comment!
Please enter your name here